Видео ютуба по тегу Biocentury

Ep. 100 - Adam Koppel on Why Private Equity Is Moving Deeper Into Biotech and What Comes Next
Ep. 100 - Adam Koppel on Why Private Equity Is Moving Deeper Into Biotech and What Comes Next
Ep. 342 - 2026 Biotech Kickoff
Ep. 342 - 2026 Biotech Kickoff
Ep. 341 - BioCentury's '25-'26 Picks. Plus: BioMarin & Biotech ICYMI
Ep. 341 - BioCentury's '25-'26 Picks. Plus: BioMarin & Biotech ICYMI
Ep. 99 – Stelios Papadopoulos on Biotech’s Long View: Pricing Pressure, China & Big Pharma
Ep. 99 – Stelios Papadopoulos on Biotech’s Long View: Pricing Pressure, China & Big Pharma
Ep. 340 - Obesity Data, Kymera & FDA Survey Results
Ep. 340 - Obesity Data, Kymera & FDA Survey Results
Ep. 339 - Biotech M&A, In Vivo CAR Ts & FDA Tumult
Ep. 339 - Biotech M&A, In Vivo CAR Ts & FDA Tumult
Ep. 98 - Inside Precision Oncology’s Next Chapter with Fore’s Bill Hinshaw
Ep. 98 - Inside Precision Oncology’s Next Chapter with Fore’s Bill Hinshaw
Popular Episode - Reimagining FDA: Steve Usdin on Designing the Drug Regulator of the Future
Popular Episode - Reimagining FDA: Steve Usdin on Designing the Drug Regulator of the Future
Ep. 337 - FDA’s Moving Goalposts & China’s Innovation Arc
Ep. 337 - FDA’s Moving Goalposts & China’s Innovation Arc
Ep. 335 - Neurology's Coming Inflection Point
Ep. 335 - Neurology's Coming Inflection Point
Ep. 334 - Pazdur’s New FDA Role, SITC & China RNAi
Ep. 334 - Pazdur’s New FDA Role, SITC & China RNAi
Ep. 97 – From NIH to Industry: Zerhouni Warns Policy & Rhetoric Threaten U.S. Science
Ep. 97 – From NIH to Industry: Zerhouni Warns Policy & Rhetoric Threaten U.S. Science
Ep. 333 - Is This Korea’s Biotech Moment?
Ep. 333 - Is This Korea’s Biotech Moment?
Ep. 332 - Obesity in Focus. Plus: What’s Next for FDA
Ep. 332 - Obesity in Focus. Plus: What’s Next for FDA
Ep. 331 - Metsera M&A Melee & Tidmarsh Ouster
Ep. 331 - Metsera M&A Melee & Tidmarsh Ouster
Ep. 330 - China's Innovation Moment
Ep. 330 - China's Innovation Moment
China's Innovation Moment
China's Innovation Moment
Ep. 96 – From Pharma Partnering to Biotech CEO: Sophie Kornowski on Boston Pharma’s Playbook
Ep. 96 – From Pharma Partnering to Biotech CEO: Sophie Kornowski on Boston Pharma’s Playbook
Ep. 329 - Novartis' $12B Avidity Buy. Plus: Base Editors
Ep. 329 - Novartis' $12B Avidity Buy. Plus: Base Editors
5th East-West Biopharma Summit: Seoul | March 9–11, 2026
5th East-West Biopharma Summit: Seoul | March 9–11, 2026
Ep. 328 - Brain Shuttles, GSK Q&A and FDA Vouchers
Ep. 328 - Brain Shuttles, GSK Q&A and FDA Vouchers
Ep. 95 - Kymera CEO Nello Mainolfi: Matching Degrader Chemistry to the Problem
Ep. 95 - Kymera CEO Nello Mainolfi: Matching Degrader Chemistry to the Problem
Ep. 326 - Market Outlook, Biosecure Returns, Biotech M&A
Ep. 326 - Market Outlook, Biosecure Returns, Biotech M&A
Ep. 325 - Pfizer MFN Deal, New Trial Paradigm & Billion $ Fund
Ep. 325 - Pfizer MFN Deal, New Trial Paradigm & Billion $ Fund
Ep. 94 - Frazier's James Li on China’s Rapidly Evolving Biotech Deal Landscape
Ep. 94 - Frazier's James Li on China’s Rapidly Evolving Biotech Deal Landscape